---
title: Antibody Corporate Bond
date: 2018-03-13
start_date: Proposed in 2015
description: The sale of 10-year government-guaranteed corporate bonds (antibiotic corporate bonds or ACBs), repaid from the sale of patent-extension certificates (PECs), to create a fund for antibiotic R&D
status: Proposed
---
